MedPAC examines Medicare quality measurement, drug spending
At meetings this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data. Commissioners also received a status report on Medicare Accountable Care Organizations. The commission will meet again in November.
Related News Articles
Headline
Individuals and families can enroll in or change their health coverage options through the Health Insurance Marketplace beginning tomorrow through Jan. 15. The…
Headline
The AHA and a coalition of organizations yesterday urged House and Senate leaders to pass the Reforming and Enhancing Sustainable Updates to Laboratory Testing…
Headline
The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model…
Headline
Rural hospital leaders recently shared strategies and insights on improving safety culture, governance and care reliability at the AHA’s Rural Patient Safety…
Blog
Rural hospital leaders from across the country came together to share strategies and insights for improving safety culture, governance and care…
Perspective
As of 2024, there were about 61 million Americans age 65 and older, according to the U.S. Census Bureau, representing about 18% of the total U.S.…